Calorie restriction-induced leptin reduction and T-lymphocyte activation in blood and adipose tissue in men with overweight and obesity

Rebecca L. Travers, William V. Trim, Alexandre C. Motta, James A. Betts, Dylan Thompson

Research output: Contribution to journalArticlepeer-review

Abstract

Background: T-Lymphocyte activation is modulated by the adipokine leptin and serum concentrations of this hormone can be reduced with short-term calorie restriction. The aim of this study was to understand whether leptin per se is important in determining levels of T-lymphocyte activation in humans, by investigating whether the reduction in leptin concentration following calorie restriction is associated with a decrease in T-Lymphocyte activation in blood and adipose tissue. 

Methods: Twelve men with overweight and obesity (age 35–55 years, waist circumference 95–115 cm) reduced their calorie intake by 50% for 3 consecutive days. Blood and subcutaneous adipose tissue were obtained for isolation of immune cells and cytokine analysis. CD4+ and CD8 + T-Lymphocytes were identified and characterised according to their expression of activation markers CD25 and CD69 by flow cytometry. 

Results: Serum leptin was reduced by (mean ± SEM) 31 ± 16% (p < 0.001) following calorie restriction. The percentage of blood CD4 + CD25 + T-lymphocytes and level of CD25 expression on these lymphocytes were significantly reduced by 8 ± 10% (p = 0.016) and 8 ± 4% (p = 0.058), respectively. After calorie restriction, ex vivo leptin secretion from abdominal subcutaneous adipose tissue explants was not changed, and this corresponded with a lack of change in adipose tissue resident T-Lymphocyte activation. 

Conclusions: Serum leptin was reduced after calorie restriction and this was temporally associated with a reduction in activation of blood CD4 + CD25 + T-Lymphocytes. In abdominal subcutaneous adipose tissue, however, leptin secretion was unaltered, and there were no observed changes in adipose resident T-Lymphocyte activation.

Original languageEnglish
Pages (from-to)993-1002
Number of pages10
JournalInternational Journal of Obesity
Volume48
Issue number7
Early online date27 Mar 2024
DOIs
Publication statusPublished - 31 Jul 2024

Data Availability Statement

All data presented in this manuscript are available, upon request, from the University of Bath’s Data Repository (https://researchdata.bath.ac.uk/id/eprint/1350).

Funding

JAB is an investigator on research grants funded by BBSRC, MRC, British Heart Foundation, Rare Disease Foundation, EU Hydration Institute, GlaxoSmithKline, Nestlé, Lucozade Ribena Suntory, ARLA foods, Cosun Nutrition Center, American Academy of Sleep Medicine Foundation and Salus Optima (L3M Technologies Ltd); has completed paid consultancy for PepsiCo, Kellogg’s, SVGC and Salus Optima (L3M Technologies Ltd); is Company Director of Metabolic Solutions Ltd; receives an annual honorarium as a member of the academic advisory board for the International Olympic Committee Diploma in Sports Nutrition. At the time of completion of these experiments, A. Motta was employed by Unilever which had an active program of glucose reduction. This is no longer the case and A. Motta works now for IMcoMET BV (The Netherlands) on an unrelated topic. This work was supported by the British Biotechnology and Biological Sciences Research Council (BBSRC) (BB/I532110/1 and BB/N004809/1) and Unilever.

FundersFunder number
Rare Disease Foundation
International Olympic Committee Diploma in Sports Nutrition
American Academy of Sleep Medicine Foundation
Medical Research Council
SVGC
Salus Optima
British Heart Foundation
Cosun Nutrition Center
GlaxoSmithKline
Unilever
EU Hydration Institute
Biotechnology and Biological Sciences Research CouncilBB/I532110/1, BB/N004809/1

Fingerprint

Dive into the research topics of 'Calorie restriction-induced leptin reduction and T-lymphocyte activation in blood and adipose tissue in men with overweight and obesity'. Together they form a unique fingerprint.

Cite this